The efficacy of night splinting in children with cerebral palsy, a randomised controlled trial - Splint

Vrije Universiteit Medisch Centrum0 个研究点目标入组 24 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•They have a clinical diagnosis of unilateral or bilateral spastic CP
•They have an age between 4-12 years old
•They have a range of motion in the ankle of 0º plantar flexion or less with an extended knee, tested by a clinician with a manual force.
•They are able to walk with or without aids (GMFCS class 1-3).
•They have a range of motion in the ankle less than 5º with an extended knee, tested by the clinician with reasonable manual force and will be treated with:
•* Botulinum toxin A injections in the m. Gastrocnemius
•* AND/OR serial casting
•* AND/OR orthotic management in rest with a Knee-Ankle-Foot-Orthosis
•o OR they have a range of motion in the ankle less than 20 degrees and more than 0 degrees dorsiflexion and they have been treated for a decreased range of motion (defined as less than 5 degrees dorsiflexion) in the ankle in the past by:
•* Botulinum toxin A injections in the m. Gastrocnemius (at least 6 months ago)
•* AND/OR serial casting (at least 3 months ago)
•* AND/OR orthotic management in rest with a Knee-Ankle-Foot-Orthosis
•They live in a stable social family situation.

•Surgery of the Gastrocnemius and/or Soleus muscle has been performed in the past.
•A Selective Dorsal Rhizotomy has been performed in the past
•There is administration of treatment of Intra Thecal Baclofen therapy
•The cannot extend their knees fully.
•They have behavioural problems or sleeping problems.
•The child is institutionalized.
•There is co-morbidity interfering with mobility.
•Parents/guardians and/or child do not understand the Dutch or English language well enough to take part in this project

发起方